UBS raised its 12-month price target to $115 from $107, but kept its Neutral rating. The higher estimate is countered by that unchanged rating, and the report gives no new company results.
A higher share-price estimate is a positive sign, but UBS still rates CCEP Neutral. The report gives no new sales or profit figures, so it offers no clear reason to change the view of the business.
Follow Coca-Cola Europacific Partners plc (CCEP) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CCEP